Austria In Vitro Diagnostics Industry Outlook 2021

See how Austria In Vitro Diagnostics performed compared to key markets such as Germany, Spain and the United Kingdom.

Key Market Indicators

Since 2013, the Austrian market has seen a steady increase of 19% year on year. By 2021, Austria ranked ninth, with Lithuania ahead at approximately €335 million. Spain, the United Kingdom, and Finland secured the second, third, and fourth spots, respectively. Austrian Diagnostic Reagent Export is projected to reach roughly $317 million by 2028, up from approximately $290 million in 2023, marking an average annual growth of 1.4%. Since 1999, the country's supply has increased by 1.5% annually. In 2023, Austria was ranked 19th, with China surpassing it at around $290 million. Germany, the Netherlands, and the United Kingdom held the second, third, and fourth positions in this category. Meanwhile, Austrian Diagnostic Reagent Import is expected to grow to about $336 million by 2028, up from around $315 million in 2023, reflecting an average annual growth rate of 1%. Since 1999, Austria's demand for diagnostic reagents has risen by 1% each year.

Austria In Vitro Diagnostics Market Data and Forecasts

How much will Austria In Vitro Diagnostics Market grow?